Astellas, Boehringer file lawsuit against Ranbaxy for patent violation (PharmaBiz)

home   >   yahoo news

Astellas Pharma Inc. and Boehringer Ingelheim Pharmaceuticals, Inc., a US subsidiary of Boehringer Ingelheim of Germany, jointly filed a patent infringement lawsuit in the United States against Ranbaxy regarding its submission of an abbreviated new drug application (ANDA) for a generic version of Astellas' drug product, sold under the trademark Flomax (generic name: tamsulosin HCl; brand name in

- link to Astellas, Boehringer file lawsuit against Ranbaxy for patent violation (PharmaBiz) -
Last update: 05/26/2005

Recommended Reading

    Plusmarquista del sectarismo.(comentarios sobre actos politicos de Rafael Simancas ) : An article from: Epoca
    Montelukast indicated for seasonal allergic rhinitis. (New FDA-Approved Indication). : An article from: Internal Medicine News
    Natalizumab maintains remission in Crohn's; drug blocks immune cell movement.(News) : An article from: Family Practice News
    Head-to-head comparison of osteoporosis drugs: alendronate vs. raloxifene.(Women's Health) : An article from: Family Practice News
    Crushed dreams: doctors use drugs to heal, but in the wrong hands, drugs can wreck lives.(Close-Up: Medications) : An article from: Scholastic Choices
    Two more drugs approved for social anxiety. (Sertraline, Venlafaxine). : An article from: Internal Medicine News
    Antipsychotic-induced metabolic syndrome costly: clinical, economic impact.(Rx)(Clozaril, Zyprexa, Seroquel, and other antipsychotics may cause diabet ... rome) : An article from: Family Practice News
    Purdue improves e-record tracking of Oxycontin adverse events after audit. (Human Drugs). : An article from: Inspection Monitor